CDMO Catalent
CDMO Catalent

Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
BIOT
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼

Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
BIOT
📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.

Novo Holdings Acquires Catalent for $165bn: Expanding Presence in Pharma Manufacturing
BIOT
📢 Novo Holdings acquires CDMO Catalent for $16.5bn, expanding their presence in pharmaceutical manufacturing and development. 💼💉🌍





